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Abstract The effect of hypoxia, induced by incubation
under low (1%) oxygen tension or by exposure to CoCl2,
on the expression and secretion of inflammation-related
adipokines was examined in human adipocytes. Hypoxia
led to a rapid and substantiali n c r e a s e( g r e a t e rt h a n
sevenfold by 4 h of exposure to 1% O2) in the hypoxia-
sensitive transcription factor, HIF-1α, in human adipocytes.
This was accompanied by a major increase (up to 14-fold)
in GLUT1 transporter mRNA level. Hypoxia (1% O2 or
CoCl2) led to a reduction (up to threefold over 24 h) in
adiponectin and haptoglobin mRNA levels; adiponectin
secretion also decreased. No changes were observed in
TNFα expression. In contrast, hypoxia resulted in substan-
tial increases in FIAF/angiopoietin-like protein 4, IL-6,
leptin, MIF, PAI-1 and vascular endothelial growth factor
(VEGF) mRNA levels. The largest increases were with
FIAF (maximum 210-fold), leptin (maximum 29-fold) and
VEGF (maximum 23-fold); these were reversed on return
to normoxia. The secretion of IL-6, leptin, MIF and VEGF
from the adipocytes was also stimulated by exposure to 1%
O2. These results demonstrate that hypoxia induces exten-
sive changes in human adipocytes in the expression and
release of inflammation-related adipokines. Hypoxia may
underlie the development of the inflammatory response in
adipocytes, leading to obesity-associated diseases.
Keywords Adipokines.Adiposetissue.Hypoxia.
Inflammation.Obesity.Metabolicsyndrome
Abbreviations
FIAF fasting-induced adipose factor
HIF-1α hypoxia inducible factor 1α
IL-6 interleukin-6
MCP-1 monocyte chemoattractant protein-1
MIF monocyte migration inhibitory factor
PAI-1 plasminogen activator inhibitor-1
POLR2A RNA II polypeptide A
TNFα tumour necrosis factor-α
VEGF vascular endothelial growth factor
Introduction
White adipose tissue has traditionally been considered as
primarily a vehicle for the storage of fuel in the form of
triacylglycerols, but several other functions are now
recognised for the tissue. In particular, adipose tissue is a
major endocrine organ secreting several key hormones,
notably leptin and adiponectin [11, 26, 29, 37, 38]. These
hormones are part of the large group of protein signals and
factors secreted by adipocytes, termed adipokines, many of
which are linked to immunity and the inflammatory
response [14, 26, 29, 38]. These encompass major
cytokines and chemokines, including TNFα, IL-1β, IL-6,
IL-10, MCP-1 and MIF [11, 26, 38].
Obesity, which is characterised by a major expansion in
adipose tissue mass, is associated with a state of chronic
mild inflammation, there being increased circulating levels
of inflammatory markers such as C-reactive protein, IL-6,
IL-18, haptoglobin, MIF and PAI-1 [11, 14, 26, 38]. The
production of a number adipokines increases during the
expansion of adipose tissue mass in the obese (for example,
leptin, MIF, TNFα and PAI-1), with the result that there is
an inflammatory state within the tissue [11, 14, 26, 38]. An
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action [25, 49]. Inflammation in WAT is considered to be
causal in the development of type 2 diabetes and the
metabolic syndrome linked to obesity [11, 14, 26, 29]. There
has, however, been little focus on why the rise in adipose
tissue mass in the obese should lead to the increased
production of inflammatory adipokines. One possibility,
which we have recently suggested, is that it is a response to
relative hypoxia in clusters of adipocytes distant from the
vasculature, inflammation serving to increase blood flow
and stimulate angiogenesis [38, 39].
Hypoxia, which occurs, for example, in solid tumours
and during wound healing, induces a series of adaptive
responses by cells, and a key role in the transmission of the
hypoxic response is played by the hypoxia-inducible
transcription factors, particularly hypoxia-inducible factor-
1 (HIF-1) [6, 13, 32, 33, 44]. HIF-1 is composed of two
subunits, HIF-1β, which is constitutively expressed, and
HIF-1α, which is recruited in response to low O2 tension to
yield the functional transcription factor [6, 32, 44]. HIF-1α
is present in murine clonal adipocytes, and hypoxia has
been shown to induce an increase in the expression of leptin
and vascular endothelial growth factor (VEGF) in these
cells [21]. Recently, hypoxia has also been reported to
induce the production of PAI-1 and to inhibit the synthesis
of adiponectin by 3T3-L1 adipocytes [4]; it is also reported
to induce the expression of visfatin in these cells [31]. HIF-
1α has been identified in human adipose tissue and is
reported to be increased in obesity [3]. However, the extent
to which human adipocytes respond to hypoxia and which
genes are hypoxia-sensitive are unknown.
In the present study, we have examined the effects of
hypoxia on the expression and secretion of key adipokines
linked to inflammation in human adipocytes differentiated
from fibroblastic preadipocytes in culture. The results
demonstrate that hypoxia, whether through low O2 tension
or induced chemically by CoCl2, leads to a marked
recruitment of HIF-1α in human adipocytes and that
expression of the GLUT1 facilitative glucose transporter
in adipocytes is hypoxia-sensitive. Importantly, the expres-
sion and secretion of several adipokines, including FIAF/
angiopoietin-like protein 4, IL-6, leptin, MIF and VEGF, is
stimulated by hypoxia in human adipocytes, while adipo-
nectin and haptoglobin are inhibited.
Materials and methods
Human adipocyte culture
Human subcutaneous preadipocytes, derived from adipose
tissue pooled from seven female subjects, were obtained
(together with culture media) from Zen-Bio (USA). The
patients had a mean body mass index of 25 (range 22.5–
28.2) and average age of 41 years (range 27–51 years).
Cells were trypsinized from a 75-cm
2 flask and plated at
a density of 40,000/cm
2 in a 24-well plate and maintained
in preadipocyte medium containing Dulbecco’s modified
Eagle’s medium (DMEM)/Ham’s F12 (1:1, v/v), 10% fetal
calf serum (FCS), 15 mM HEPES, 100 U/ml penicillin,
100 μg/ml streptomycin and 0.25 μg/ml amphotericin B at
37°C in a humidified atmosphere of 95% air/5% CO2. Cells
were induced at confluence by incubation in differentiation
medium composed of adipose medium (AM) supplemented
with 0.25 mM isobutyl methylxanthine and 10 μMo fa
PPARγ agonist for 4 days. The cells were then cultured
with AM containing DMEM/Ham’s F-12 (1:1, v/v), 3%
FCS, 1 μM dexamethasone, 100 U/ml penicillin, 100 μg/ml
streptomycin and 0.25 μg/ml amphotericin B. The medium
was changed every 3 days.
Fully differentiated cells at day 15 post-induction were
treated with CoCl2 or exposed to 1% O2 for up to 24 h. For
CoCl2 treatment, wells incubated without CoCl2 were used
as controls; 75–200 μM CoCl2 was used in initial experi-
ments, and 100 μM CoCl2 was employed in a time course
study. For exposure to hypoxia, the cells were transferred to
a MIC-101 modular incubator chamber (Billups-Rosenberg,
USA), which was flushed with 1% O2, 94% N2 and 5%
CO2, and sealed and placed at 37°C for up to 24 h as
indicated. The control cells were cultured in a standard
incubator (21% O2 and 5% CO2). The cells were harvested
in 700 μl of Trizol (Invitrogen, UK) or 150 μl of lysis
buffer per well at the stated time points. Media were
collected and centrifuged at 1,000 rpm for 10 min to
remove cell debris and the supernatant stored at −20°C until
required for analysis. All incubations at each time point
were performed in replicates of up to six wells.
RNA extraction and cDNA synthesis
Total RNAwas isolated from cells using Trizol, and 1 μgo f
RNA was treated with DNase I (Invitrogen) according to
the manufacturer’s instructions. RNA concentration was
quantified from the absorbance at 260 nm; all samples had
a 260/280 nm absorbance ratio of 1.7–1.9.
One microgram of DNase I-treated RNA was reverse-
transcribed using a Reverse-iT™ 1
ST strand synthesis kit
(Abgene, UK) in the presence of anchored oligo dT in a
total volume of 20 μl.
Real-time PCR
Quantitative real-time polymerase chain reactions (PCRs)
were carried out in a final volume of 12.5 μl consisting of
12.5–50 ng of reverse-transcribed cDNA mixed with
optimal concentrations of primers and probe and qPCR™
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detector (Stratagene, USA).
The primer and probe sets were designed using Primer
Express software (Applied Biosystems) and synthesized
commercially; the primers and TaqMan probes were from
Eurogentec. TaqMan probes were labelled with a reporter
fluorescent dye (FAM: 6-carboxyfluorescein) at the 5′-end
and a fluorescent dye quencher (TAMRA: 6-carboxy-
tetramethyl-rhodamine) at the 3′-end. The sequence and
optimal concentrations of primers and probes, together with
the size of products, are as detailed previously [41, 42],
with the exception of GLUT1, FIAF, HIF-1α, MIF and
POLR2A which were as follows.
GLUT1 (93 bp): 5′-ATACTCATGACCATCGCGCTAG-3′
(forward), 5′-AAAGAAGGCCACAAAGCCAAAG-3′ (re-
verse) and 5′-FAM-TGGAGCAGCTACCCTGGATGTCC
TATCTGA-TAMRA-3′ (probe);
FIAF (117 bp): 5′-GATGGCTCAGTGGACTTCAACC-3′
(forward), 5′-CCCGTGATGCTATGCACCTTC-3′ (reverse)
and 5′-FAM-CCAGACCCAGCCAGAACTCGCCGT-
TAMRA-3′ (probe);
HIF-1α (75 bp): 5′-TCCAGTTACGTTCCTTCGATCA-3′
(forward), 5′-TTTGAGGACTTGCGCTTTCA-3′ (reverse)
and 5′-FAM-CACCATTAGAAAGCAGTTCCGCAAGCC-
TAMRA-3′ (probe);
MIF (74 bp): 5′-AGCCCGGACAGGGTCTACA-3′ (for-
ward), 5′-GCGAAGGTGGAGTTGTTCCA-3′ (reverse)
and 5′-FAM-CTATTACGACATGAACGCGGCCAATGT-
TAMRA-3′ (probe);
POLR2A (81 bp): 5′-ATGGAGATCCCCACCAA
TATCC-3′ (forward), 5′-CATGGGACTGGGTGCTGAAC-3′
(reverse) and 5′-FAM-TGCTGGACCCACCGGCATGTTC
TAMRA-3′ (probe).
Typically, the amplification started with 2 min at 50°C,
10 min at 95°C and then 40 cycles of the following: 15 s at
95°C and 1 min at 60°C.
Human POLR2A was used as an endogenous reference.
This housekeeping gene was selected based on comparison
with β-actin, where POLR2A demonstrated no significant
changes in expression when exposed to CoCl2 and 1% O2
(data not shown). Relative quantitation values were
expressed using the 2ΔΔCt method (see user bulletin no.
2, ABI Prism 7700, pp 11–15, Applied Biosystems), as fold
changes in the target gene normalised to the reference gene
(POLR2A) and related to the expression of the untreated
controls. The PCR efficiency in all runs was close to 100%,
and all samples were analysed in at least duplicate.
Measurement of HIF-1α and adipokines by ELISA
Total HIF-1α in cell lysates was measured with an enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems,
UK) according to the manufacturer’s protocol. Cells were
solubilised in lysis buffer consisting of 50 mM Tris (pH 7.4),
300 mM NaCl, 10% (w/v) glycerol, 3 mM ethylenediami-
netetraacetic acid, 1 mM MgCl2,2 0m Mβ-glycerophos-
phosphate, 25 mM NaF, 1% Triton X-100, 25 μg/ml
leupeptin, 25 μg/ml pepstatin and 3 μg/ml aprotinin.
Before measuring HIF-1α by ELISA, the total protein
content of the lysates was determined by the BCA protein
assay reagent (Sigma, UK).
Adiponectin, IL-6, leptin, MIF and VEGF were mea-
sured in cell culture media using commercial ELISA kits
(R&D Systems). The assays were conducted in 96-well
microplates according to the manufacturer’s instructions.
Measurement of HIF-1α by Western blotting
Samples were prepared as described above for the HIF-1α
ELISA assay. Fifteen micrograms of protein were separated
by sodium dodecyl sulfate–polyacrylamide gel electropho-
resis and then transferred to a nitrocellulose membrane. The
membranes were blocked and probed with polyclonal goat
anti-human HIF-1α (R&D Systems) or mouse monoclonal
anti-α-tubulin (Sigma, UK) as the primary antibody, then
subjected to HRP-conjugated anti-goat IgG (R&D systems)
or anti-mouse IgG (Santa Cruz Biotechnology) as the
secondary antibody. Specific proteins were visualised with
the enhanced chemiluminescence reagent (Amersham, UK).
Statistical analysis
The results are expressed as mean values±SE. Differences
between groups were analysed by unpaired two-tailed
Student’s t tests.
Results
HIF-1α expression during differentiation of human
adipocytes
We first investigated whether human white adipocytes
express the HIF-1α gene and synthesize the encoded
protein when differentiated in culture. Quantitative changes
in HIF-1α gene expression after the induction of adipocyte
differentiation were analysed by real-time PCR. Although
the HIF-1α gene was expressed both before and after
differentiation, there was a marked decrease in HIF-1α
mRNA level after differentiation was induced (Fig. 1a): By
day 2, the mRNA level fell to <25% of that seen at day 0
and remained low. The expression of a classical adipokine–
leptin— was determined as a reference gene. As expected,
leptin mRNA was differentiation-dependent and detectable
only at day 2 after the induction of differentiation,
increasing progressively thereafter (Fig. 1b).
Pflugers Arch - Eur J Physiol (2007) 455:479–492 481HIF-1α protein expression was examined at day 0 and
day 14 using a specific ELISA and was detected at both
time points. In parallel with the mRNA level, HIF-1α
protein was substantially higher in preadipocytes than in
adipocytes (Fig. 1c).
Response to CoCl2 treatment
Hypoxic effects can be mimicked by the divalent transition-
metal ioncobalt.Inthe next experiments,differentiatedhuman
adipocytes (day 15 post-induction) were treated with CoCl2 at
concentrations of 75 and 200 μM for 24 h. CoCl2 treatment
resulted in a marked increase in total HIF-1α protein, the
level being fivefold higher at both doses compared to
untreated cells (Fig. 2a). In contrast, HIF-1α mRNA level
was reduced three to fivefold by CoCl2 treatment (Fig. 2b).
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Fig. 2 Effect of CoCl2 at two dose levels on HIF-1α protein
concentration (a) and on the mRNA levels of HIF-1α, GLUT1 and
adipokines (b) in human adipocytes. Differentiated human adipocytes
at day 15 were incubated in medium containing 75 or 200 μM CoCl2
for 24 h. Total HIF-1α protein and mRNA level of adipokines were
measured as described in Fig. 1. Results are means±SE (n=6). In a,
**P<0.01, ***P<0.001 compared with controls; in b †P<0.001
compared with controls. Open bars, controls; shaded bars, 75 and
200μm CoCl2 (light and dark bars, respectively)
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Fig. 1 Time course of quantitative changes in HIF-1α mRNA level
(a), leptin mRNA level (b) and HIF-1α protein (c) during the
differentiation and development of human adipocytes. Confluent
human preadipocytes (day 0) were differentiated and cultured for up
to 14 days. Relative mRNA levels were normalised to human
POLR2A at day 0 (or day 2 when no signal was evident at day 0).
Total protein concentration of HIF-1α in cell lysates was measured by
ELISA. Results are means±SE (n=3)
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CoCl2-induced increase in HIF-1α protein by increasing
the expression of ‘classical’ hypoxia-sensitive genes, the
mRNA level of the GLUT1 facilitative glucose transporter
was examined as a reference; this gene is recognised in other
cells to be upregulated under hypoxic conditions. Treatment
with CoCl2 induced a sixfold increase in GLUT1 mRNA
level in the adipocytes (Fig. 2b).
The expression of a series of inflammation-related
adipokine genes was then examined in the CoCl2-treated
adipocytes, and three distinct responses were observed. No
effect was found on TNFα or adipsin mRNA level at either
of the two doses of CoCl2. There was, however, a
significant reduction in mRNA level for adiponectin,
MCP-1 and haptoglobin (Fig. 2b). Adiponectin mRNA
level was decreased three to fourfold, MCP-1 by up to
fivefold and haptoglobin mRNA by less than half with both
concentrations. In the case of IL-6, the high dose of CoCl2
reduced mRNA level threefold, but there was no response
with the lower dose (Fig. 2b). In contrast, CoCl2 treatment
resulted in a marked increase in mRNA level for FIAF,
leptin, MIF, PAI-1 and VEGF. The increase was six to
sevenfold for VEGF and FIAF, and two to fourfold for PAI-1,
MIF and leptin (Fig. 2b).
Time course of response to CoCl2
The previous experiment indicated that in most cases, there
was little difference in the effect of 75 or 200 μM CoCl2 on
HIF-1α protein level and adipokine gene expression.
However, with leptin, MIF and PAI-1 in particular, effects
were noted with the lower, but not the higher, dose. This
might suggest the possibility of additional, or toxic,
responses to CoCl2 at higher doses. Consequently, in the
subsequent time course study, a concentration of 100 μM
was employed at day 15 post-induction. There was a rapid
and significant accumulation of HIF-1α protein in human
adipocytes after the addition of CoCl2. The protein level
was increased 4.7-fold by 2 h of CoCl2 treatment and
peaked at 8 h, at which point it was increased 7.7-fold
before gradually falling (Fig. 3a). HIF-1α protein level was
also assessed by Western blotting, and the pattern of results
was similar to that obtained by ELISA (Fig. 3b).
GLUT1 was again used as a hypoxia-sensitive reference
gene, and the pattern of the time course of the changes in
GLUT1 mRNA level was similar to that of HIF-1α protein.
The mRNA level was significantly increased (2.3-fold) by
2 h, peaking at 8 h, at which point it was 14-fold higher,
gradually declining thereafter (Fig. 3c).
The time course of the effect of CoCl2 on the expression
of genes encoding adipokines was next examined. A group
of adipokines including FIAF, IL-6, leptin, MIF, PAI-1 and
VEGF showed marked increases in mRNA level in
response to CoCl2, some of which were both substantial
and rapid. FIAF mRNA level was increased 30-fold by 2 h
after the addition of CoCl2, peaking at 8 h, at which point
it, had risen 210-fold (Fig. 4a). There was a fall thereafter,
but even at 24 h, FIAF mRNA was still elevated 30-fold. A
similar pattern was also evident with IL-6, PAI-1 and
VEGF, but the changes were not as large (Fig. 4a). In
comparison to the above genes, there was a more gradual
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Fig. 3 Time course of effects of CoCl2 (100 μM) on total HIF-1α
protein level (a and b) and GLUT1 mRNA levels (c)i nh u m a n
adipocytes. Cells were cultured and treated as in Fig. 2.R e s u l t sa r e
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Fig. 4 Time course of effects of
CoCl2 (100 μM) on adipokine
mRNA levels of FIAF, IL-6,
leptin, MCP-1, MIF, PAI-1,
TNF-α and VEGF (a) and adi-
ponectin, haptoglobin and adip-
sin (b) in human adipocytes.
Relative mRNA levels. Cells
were cultured and treated as in
Fig. 2. Results are means±SE
(n=4). *P<0.05, **P<0.01,
***P<0.001 compared with
0-h controls
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reaching a peak (fourfold) at 16 h, with little change for the
rest of the 24-h incubation period (Fig. 4a). Intriguingly,
MCP-1 mRNA level exhibited a substantial acute increase,
being elevated >20-fold at 2 h, but there was a rapid decline
thereafter such that at 16 and 24 h the levels were similar to
the controls (Fig. 4a).
In contrast, to the genes described so far, no effect was
found on mRNA level throughout the 24-h incubation
period in the case of adipsin (Fig. 4b), while TNFα mRNA
was also unchanged except for a transitory increase at 2 h
only (Fig. 4a). There was, however, a significant reduction in
mRNA level for adiponectin and haptoglobin after 8–16 h of
the treatment; by 24 h, adiponectin and haptoglobin mRNA
was decreased by 15.7-fold and threefold, respectively
(Fig. 4).
Induction of HIF-1α protein and GLUT1 gene expression
by low O2 tension
In the next set of experiments, the direct effects of low O2
tension were examined. Human adipocytes at day 15 post-
differentiation were exposed to normoxic conditions (21% O2)
or to 1% O2 for up to 24 h. Some cells were returned to
n o r m o x i af o r1 6ha f t e r8ho fe x p o s u r et o1 %O 2 to examine
the reversibility of responses. Total HIF-1α protein level was
measured by both ELISA and Western blotting. HIF-1α
concentration in cells was rapidly and substantially upregu-
lated on exposure to 1% O2, being 7.8-fold higher by 4 h than
in control cells cultured under normoxia. The HIF-1α level
fell markedly after 8 h, but at 24 h, it was still 3.8-fold higher
than in control cells (Fig. 5a). The transfer of adipocytes back
to normoxic conditions after 8 h at 1% O2 l e dt oar a p i df a l l
in HIF-1α, the level of the protein at 1 h being threefold
lower than in cells maintained in 21% O2 throughout (the
cells were returned to normoxia after 8 h, rather than 24 h,
because the high level of HIF-1α at the earlier time point
facilitated assessment of changes with normoxia). By 16 h
after the return to normoxia, the level of HIF-1α was similar
to that in the control adipocytes. The pattern of HIF-1α level
as determined by ELISA was mirrored by Western blot
analysis (Fig. 5b).
GLUT1 mRNA level was markedly increased (fivefold)
after 4 h of exposure to 1% O2 (Fig. 5c) and reached a peak
at 24 h, being 14-fold higher than in cells maintained under
normoxia. After exposure to hypoxia for 8 h, the level of
GLUT1 mRNA returned to normal after 16 h in 21% O2
(Fig. 5c).
Regulation of adipokine gene expression by low O2 tension
The effect of hypoxia on the expression of genes encoding
key inflammation-related adipokines was next examined.
The first group of adipokines, which encompassed FIAF,
IL-6, leptin, MIF, PAI-1 and VEGF, exhibited rapid and
marked increases in mRNA level in response to hypoxia, as
with CoCl2 treatment. FIAF mRNA level was increased
3.3-fold by 4 h after exposure to 1% O2, rising to 11-fold
by 24 h (Fig. 6a). FIAF mRNA level was completely
normalised by 16 h of reexposure to normoxia after 8 h in
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Fig. 4 (continued)
Pflugers Arch - Eur J Physiol (2007) 455:479–492 4851% O2. A similar pattern was also evident with five other
adipokines. The changes were even more substantial in the
case of leptin and VEGF. After 4 h of hypoxia, leptin and
VEGF mRNA levels were increased four to fivefold and
rose such that at 24 h they were 29-fold and 23-fold greater
than in controls, respectively (Fig. 6a). Again, after 16 h of
reexposure to normoxia after 8 h in 1% O2, the mRNA
level of these two adipokines had returned to normal.
IL-6,MIFandPAI-1mRNAlevelsalsoshowedsignificant
increases in response to hypoxia, but these increases (2.5-fold
to fivefold at 24 h), were less than those exhibited by FIAF,
leptinandVEGF.Returningtheadipocytesto21%O2 led to a
reversal by 16 h of the hypoxia-induced increases in IL-6,
MIF and PAI-1 mRNA levels; in the case of IL-6, the
mRNA was lower than in control cells at 16 h after the
transfer from hypoxic to normoxic conditions.
In contrast to the genes described so far, there was a
significant reduction in adiponectin and haptoglobin
mRNA levels by the end of the 24-h exposure period, the
decrease being two to threefold (Fig. 6b). This reduction
was reversed after 1 h of reexposure to 21% O2, but
surprisingly was evident again after 16 h of reexposure.
Adipsin mRNA level showed a significant, but very small,
increase at 8 and 16 h (1.5 and 1.7-fold, respectively).
There were no significant changes in the level of TNFα
mRNA during exposure to 1% O2, while MCP-1 mRNA
was also unchanged after 4 and 24 h of hypoxia. For
reasons that are not apparent, there was a significant
reduction in MCP-1 mRNA at 8 h, and this was sustained
1 h after return to normoxia (Fig. 6b).
Adipokine secretion in hypoxia
The secretion into the medium of a selected group of
adipokines was examined during the exposure to hypoxia
using specific ELISAs. A small but statistically significant
reduction in adiponectin secretion was observed after 8 and
24 h incubation under 1% O2 (Fig. 7a). This reduction was
not evident after reexposure to 21% O2 for 16 h (Fig. 7a).
In marked contrast to adiponectin, there was a significant
increase in leptin, MIF and VEGF release after both 8 and
24 h exposure to hypoxia (Fig. 7c–e). The increases in
secretion were modest for MIF, but substantial in the case
of both leptin and VEGF. Thus, after 24 h of hypoxia,
leptin release was tenfold higher, while that of VEGF was
fourfold greater. Elevated rates of secretion were still
evident after transfer of the adipocytes from hypoxic to
normoxic conditions, indicating a long-term carryover
effect of low O2 tension. The secretion of IL-6 was not
altered after 8 h of exposure to hypoxia, but it was
significantly increased at 24 h (Fig. 7).
Discussion
An important recent development in our understanding of
obesity is the emergence of the concept that it is
characterised by a state of chronic low-grade inflammation
[7, 9, 38]. White adipose tissue produces a number of
adipokines linked to inflammation, including adiponectin,
IL-1β, IL-6, TNFα, MCP-1 and MIF [11, 14, 26, 38], and
their synthesis is generally substantially increased in
obesity—with the exception of adiponectin whose produc-
tion and circulating levels fall [15, 45]. We have recently
proposed that hypoxia may occur in adipocytes distant from
the vasculature as adipose tissue mass expands and that this
underlies the inflammatory response exhibited by the tissue
[38]. The central aim of the present study was to examine
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key inflammation-related adipokines in human adipocytes.
The transcription factor HIF-1 is a key signal in the
cellular response to hypoxia, the α-subunit of which is
highly induced by hypoxia [13, 32, 44]. HIF-1α expression
was evident in human adipocytes, as noted previously in
murine fat cells, and the level of both the mRNA and the
protein fell after the induction of differentiation. It has been
reported previously that HIF-1α mRNA level in 3T3-L1
cells peaked at 3 h after the addition of induction medium
and then rapidly decreased [16]. Immunoreactive HIF-1α
has been reported in murine adipocytes, and hypoxia results
in an increase in the amount of the protein in cultured fat
cells [4, 21]. We have observed that the HIF-1α gene is
expressed in human, mouse and rat WAT depots, and
expression occurs in both the mature adipocytes and in the
cells of the stromal vascular fraction. A previous study has
suggested that HIF-1α is predominantly expressed in the
stromal vascular fraction of obese subjects [3].
Hypoxia stabilises HIF-1α protein, which is otherwise
(under normoxic conditions) degraded by an ubiquitin-
dependent proteasome [32]. Total HIF-1α protein level in
human adipocytes increased rapidly and substantially under
hypoxic condition, both with 1% O2 and by treatment with
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Pflugers Arch - Eur J Physiol (2007) 455:479–492 487CoCl2. The elevated HIF-1α protein rapidly fell on return
to 21% O2, and the level was even decreased compared to
controls after 1 h of reoxygenation. Thus, the accumulated
HIF-1α in human adipocytes is rapidly degraded on
returning to normoxia. Indeed, it was observed in another
human adipocyte system (SGBS cells) that HIF-1α protein
declined to control levels by just 10 min after return to 21%
O2 (Wang, unpublished results).
CoCl2, a known inducer of HIF-1α, has been widely
employed as a hypoxia mimic and was used here to
examine the effects of chemically induced hypoxia on
adipokine gene expression. Previous studies have shown
that at a global gene expression level, both CoCl2 and
ambient hypoxia regulate a similar group of genes, and the
observed similarity in gene expression appears to be
dependent on functional HIF-1α [40]. CoCl2 stabilises
HIF-1α under normoxia via inhibition of the iron-contain-
ing HIF prolyl hydroxylase enzyme, which plays a critical
role in mediating normal hypoxic signalling by modifying
HIF-1α and targeting it for degradation.
Our results demonstrate that CoCl2 rapidly induces an
accumulation of HIF-1α and influences the expression of
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Other studies have also found that CoCl2 (100 μM) causes
HIF-1α accumulation in various cell types, including bone
marrow stromal cells, cancer cells and brown adipocytes
[20, 24, 27]. In contrast to protein levels, HIF-1α mRNA
level was inhibited by CoCl2 treatment. This indicates that
CoCl2 modulates HIF-1α at the posttranslational rather than
the transcriptional level. There is, however, evidence for
hypoxic induction of HIF-1α mRNA in some cells [17, 43].
Under hypoxia, GLUT1 gene expression has been
shown to increase in several cell types, including rat liver
cell lines and fibroblasts [1, 5], Chinese hamster ovary cells
[48] and in human cancer cells [12]. Our data demonstrate
that GLUT1 expression is also substantially upregulated by
hypoxic conditions in human adipocytes. Measurement by
Westernblotting(usingaspecificantibody)ofGLUT1intotal
tissue lysates of adipocytes exposed to 1% O2 demonstrated
that the level of the protein was also increased by hypoxia; at
24 h, GLUT1 protein was eightfold higher than in the
normoxic controls (Wood, unpublished results). This phe-
nomenon presumably reflects an adaptation of glucose
metabolism to hypoxic conditions, with a marked stimulation
of glycolysis in the face of a fall in aerobic metabolism.
During the adaptive response to hypoxia, the expression
of several genes encoding glycolytic enzymes is recognised
to increase [34]. To sustain higher levels of glycolysis, there
is a need for an increase in glucose uptake, and this would
be aided by an increase in the level of GLUT1 expression
in hypoxia. GLUT1 is a key facilitative glucose transporter
in white adipocytes, but other transporter isoforms such as
GLUT4, GLUT8, GLUT10 and GLUT12 are also
expressed in the cells [46, 47].
The main focus of the present study was the effects of
hypoxia on the expression and secretion of adipokines, and
qualitatively similar results were obtained over the same
time scale with both 1% O2 and CoCl2 treatment. Given the
mechanism of action of CoCl2, this is consistent with the
effects of hypoxia on adipokine production being mediated
by HIF-1. Of the adipokines studied, the expression of
TNFα and adipsin were not altered, and these genes would
seem not to be hypoxia-sensitive. However, the expression
of both adiponectin and haptoglobin (an acute phase
protein) in human adipocytes was reduced by hypoxic
conditions, and in the case of adiponectin, this was also
Fig. 7 Time course of effects of hypoxia (1% O2) on the release of
adipokines from human adipocytes. Adiponectin secretion (a) and IL-
6, leptin, MIF and VEGF release (b–e) after exposure to hypoxia.
Adipokine concentration was measured by ELISA in the medium of
cells cultured as in Fig. 6; some cells were transferred back to
normoxic conditions (21% O2) after 8 h of hypoxia and the adipokine
concentration then measured 16 h later (8- to 16-h group). Values are
means±SE (n=6). *P<0.05, **P<0.01, ***P<0.001 compared with
controls
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Pflugers Arch - Eur J Physiol (2007) 455:479–492 489evident at the level of the secretion of the protein into the
medium. The reduction, albeit modest, in adiponectin
production in human adipocytes by hypoxia is consistent
with a recent report in murine 3T3-L1 adipocytes [4]. There
was a discrepancy in the present study between the changes
in the scale of alterations in adiponectin mRNA level and
the amount of adiponectin secreted into the medium. This
may, however, reflect the lag between changes in mRNA
and alterations in secreted protein.
In marked contrast to adiponectin, hypoxia stimulated
the expression of the genes encoding FIAF, IL-6, leptin,
MIF, PAI-1 and VEGF. VEGF is involved in the develop-
ment of the vascular system, promoting angiogenesis, and
is well known to be activated by hypoxia [50]. In the
present study, an increase in VEGF protein secretion, as well
as mRNA level, was observed in human adipocytes with
hypoxia. This is in agreement with studies on rat omental
adiposetissueandonmurine3T3-F442A adipocytes[21, 51].
Leptin is the most extensively studied adipokine, and
adipose tissue is quantitatively the main leptin-producing
organ. Activation of leptin gene expression by hypoxia
resulted in a substantial increase in leptin release by human
adipocytes. This would be expected to reduce food intake
and stimulate energy expenditure, and as such, hypoxia
could provide a mechanistic basis for the increase in leptin
as adipose tissue mass expands in obesity. Leptin has been
reported to be an angiogenic factor [35], and the physio-
logical significance of a hypoxia-mediated induction of
leptin secretion by adipocytes may relate to a local effect to
stimulate the development of new blood vessels during
adipose tissue expansion. Therefore, increased leptin
production, together with that of VEGF, under hypoxic
conditions could also reflect an adaptive process to promote
angiogenesis, allowing appropriate oxygenation of adipose
tissue. It has been previously established that leptin is a
hypoxia-inducible hormone, and its production is increased
by hypoxia in tissues such as the placenta, cardiac
myocytes and cancer cells [8, 10, 23] as well as in murine
3T3-F442A adipocytes [21].
FIAF (also known as angiopoietin-like protein 4) is
expressed particularly in adipose tissue and the liver, and
has been suggested to play a role in adipose differentiation,
systemic lipid metabolism and energy homeostasis [18]. In
parallel with the activation of leptin and VEGF, FIAF
expression was highly activated by hypoxia in human
adipocytes; FIAF expression has also been shown to be
hypoxia-sensitive in cardiomyocytes through a HIF-1-
dependent pathway [2]. The major upregulation of FIAF
by hypoxia in adipocytes may again relate to angiogenesis,
this being one of the functions suggested for this protein
[22]. However, a major effect of FIAF is in the clearance of
plasma triglycerides through an inhibition of lipoprotein
lipase, and it also appears to stimulate lipolysis [18]. Thus,
the hypoxia-induced stimulation of FIAF production may
alter lipid utilisation.
The present study shows that the expression and release
of MIF, a potent macrophage migration inhibitory factor
which has recently been shown to be secreted from human
adipocytes [36], was also stimulated by hypoxia. MIF has
been described as a pro-inflammatory agent, and elevated
expression has been seen in many inflammatory patholo-
gies. Although MIF may play a role in the normal adaptive
response to hypoxia, it is likely that exaggerated expression
of MIF may contribute to the inflammatory state. It has also
been proposed that MIF may play an important role in
oncogenic transformation and tumour survival, and recent
studies have implicated MIF in the regulation of VEGF
expression [28]. In this context, during hypoxia, elevated
MIF expression may play an important role in enhancing
angiogenesis as well as macrophage recruitment. In contrast
to MIF, no consistent pattern was observed with MCP-1, an
important factor in macrophage recruitment; the acute, but
transitory, increase in MCP-1 mRNA observed with CoCl2
may reflect an effect of the metal unrelated to hypoxia.
The expression and release of the classic inflammatory
factor IL-6 was significantly upregulated by hypoxia. Thus,
hypoxia can directly affect key components of the inflamma-
tory cascade within adipose tissue. The expression of PAI-1,
an acute phase protein involved in fibrinolysis, was modestly
increasedinhumanadipocytesbyhypoxia,consistentwiththe
effectsobservedin3T3-L1adipocytes[4]. Induction of PAI-1
expression by hypoxia has also been reported in HepG2 cells
[19] and in vascular smooth muscle cells [30].
Overall, the present results indicate that a number of
genes are hypoxia-sensitive in human adipocytes and
suggest that HIF-1 is involved in the transmission of the
response to low O2 tension in these, as in other, cell types.
The hypoxia-sensitive genes in adipocytes include those
involved in basic metabolic processes, such as glucose
transport, as well as those linked to energy balance,
inflammation and angiogenesis. The stimulation of IL-6,
leptin, MIF, PAI-1 and VEGF expression, together with the
downregulation of adiponectin synthesis, is consistent with
our recent proposal that hypoxia may underlie the inflam-
matory response in adipose tissue in obesity and play a
causal role in the development of obesity-associated
diseases [38]. There was, however, no effect of hypoxia
on the expression of TNFα, a key pro-inflammatory
cytokine. The hypoxia-induced changes in IL-6 and
adiponectin, with its anti-inflammatory action, in particular,
might be expected to impact on insulin sensitivity.
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